Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BWV-201
- Development stage
- Preclinical
- Lead developer
- Onconetix
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intranasal
01
Overview
BWV-201 is a live attenuated, intranasally delivered, serotype-independent vaccine targeting *Streptococcus pneumoniae*. Its primary indications are the prevention of acute otitis media in children and pneumococcal pneumonia in the elderly. The vaccine is designed to provide broad protection against multiple serotypes of pneumococcus, aiming to improve on current vaccine approaches that target only a subset of serotypes. BWV-201 is being developed by Blue Water Biotech and is considered their lead vaccine candidate. The candidate leverages proprietary technology licensed from the University of Oxford, Cincinnati Children’s Hospital Medical Center, St. Jude Children’s Hospital, and the University of Texas Health Science Center at San Antonio[1][5][7].
- Brand names
- NasaVa
- Other names
- BWV-201BWV201BWV 201Intranasal pneumococcal vaccine
Beyond the preview
Go deeper on BWV-201.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BWV-201.